PIM2
MOLECULAR TARGETPim-2 proto-oncogene, serine/threonine kinase
PIM2 (Pim-2 proto-oncogene, serine/threonine kinase) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting PIM2
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | sp600125 | 1.79 | 5 |
| 2 | Quercetin | 1.10 | 2 |
| 3 | Apigenin 5,7,4'-trihydroxy-flavone, | 0.69 | 1 |
| 4 | Pueraria | 0.69 | 1 |
| 5 | fisetin | 0.69 | 1 |
| 6 | Genistein | 0.69 | 1 |
| 7 | Kaempferols | 0.69 | 1 |
| 8 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | 0.69 | 1 |
| 9 | myricetin-3-O-galactopyranoside [Supplementary Concept] | 0.69 | 1 |
| 10 | Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as | 0.69 | 1 |
About PIM2 as a Drug Target
PIM2 (Pim-2 proto-oncogene, serine/threonine kinase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented PIM2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
PIM2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.